Jenna Kearly, EDC Study Build Project Lead for Frontier Science, presented at the Medidata NEXT meeting held in NYC Oct 24-25, 2018.
Frontier Science was asked to participate in a breakout panel discussion, led by Andrew Newbigging, the founder of TrialGrid software, to discuss Approaches to Ensure High Quality Rave Study Builds. Christopher Tyers from ICON Clinical Research also participated. Jenna, who heads our EDC Study Build department, presented on behalf of Frontier Science. Jenna’s presentation, “Ensuring Quality in Medidata Rave Study Builds,” outlined how Frontier Science approaches study build documentation, testing and validation as part of our quality process.
Frontier Science has been building studies in Rave for over 3 years. NEXT is Medidata’s yearly conference held around the world, with NYC being their biggest turnout since it is also their corporate headquarters.